Publication: The effect of probiotic yogurt on glycemic control in type 2 diabetes or obesity: A meta-analysis of nine randomized controlled trials
2
Issued Date
2019-03-01
Resource Type
ISSN
20726643
Other identifier(s)
2-s2.0-85063672969
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Nutrients. Vol.11, No.3 (2019)
Suggested Citation
Elena Barengolts, Emily Daviau Smith, Sirimon Reutrakul, Livia Tonucci, Thunyarat Anothaisintawee The effect of probiotic yogurt on glycemic control in type 2 diabetes or obesity: A meta-analysis of nine randomized controlled trials. Nutrients. Vol.11, No.3 (2019). doi:10.3390/nu11030671 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/49803
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The effect of probiotic yogurt on glycemic control in type 2 diabetes or obesity: A meta-analysis of nine randomized controlled trials
Abstract
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. Probiotic yogurt is suggested as a nutritional approach in type 2 diabetes (T2D) and obesity. We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating the effects of probiotic yogurt on glycemic outcomes in T2D or obesity. The databases used to search for RCTs included Medline and Scopus. The RCTs were eligible if outcomes included selected glycemic markers. In nine eligible trials, 237 and 235 subjects were in treatment (probiotic yogurt) and control (mostly conventional yogurt) groups, respectively. There was no significant difference for pooled unstandardized mean difference (USMD) hemoglobin A1c (HbA1c) by probiotic yogurt compared with the control in T2D (USMD: -0.366; 95% CI: -0.755, 0.024, p = 0.066) and obesity (USMD: 0.116, 95% CI: -0.007, 0.238, p = 0.065). Similarly, there were no effects of probiotic yogurt on fasting blood glucose, fasting insulin, or insulin resistance (estimated by homeostatic model assessment of insulin resistance (HOMA-IR)) in either T2D or obesity. In conclusion, the present meta-analysis has not demonstrated the benefits of consuming probiotic compared with conventional yogurt for improving glucose control in patients with diabetes or obesity. Larger trials are needed to verify the benefits of probiotic and/or conventional yogurt or other probiotic fermented milk (e.g., kefir) on glycemic markers in patients with diabetes and obesity.